STOCK TITAN

Elite Health Systems (EHSI) CEO-linked entity buys 1,707 shares at $1.08

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Elite Health Systems Inc. director and CEO Jeereddi Prasad Anjaneya reported an indirect open-market purchase of 1,707 shares of Common Stock at $1.08 per share on April 29, 2026. After this transaction, the indirectly held position through Haven Hospital LLC totaled 227,423 shares.

Positive

  • None.

Negative

  • None.
Insider jeereddi Prasad Anjaneya
Role CEO
Bought 1,707 shs ($2K)
Type Security Shares Price Value
Purchase Common Stock 1,707 $1.08 $2K
Holdings After Transaction: Common Stock — 227,423 shares (Indirect, By Haven Hospital LLC)
Footnotes (1)
Shares purchased 1,707 shares Open-market purchase of Common Stock on April 29, 2026
Purchase price $1.08 per share Price paid for EHSI Common Stock in the reported trade
Post-transaction holdings 227,423 shares Indirect Common Stock position after the transaction
Net buy shares 1,707 shares Net change in non-derivative position reported in this Form 4
open-market purchase financial
"transaction_action: "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
indirect ownership financial
"direct_or_indirect: "I" and nature_of_ownership: "By Haven Hospital LLC""
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
jeereddi Prasad Anjaneya

(Last)(First)(Middle)
840 TOWNE CENTER DRIVE

(Street)
POMONA ARKANSAS 91767

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Elite Health Systems Inc. [ EHSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/29/2026P1,707A$1.08227,423IBy Haven Hospital LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
The securities are held by Haven Hospital LLC, of which the Reporting Person is the owner/member.
Prasad Anjaneya Jeereddi05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did EHSI report in this Form 4?

Elite Health Systems Inc. reported an indirect insider purchase. An entity associated with CEO and director Jeereddi Prasad Anjaneya bought 1,707 shares of Common Stock in an open-market transaction, reflecting a modest increase in the insider’s indirect ownership position.

How many Elite Health Systems (EHSI) shares were bought and at what price?

The filing shows a purchase of 1,707 EHSI shares at $1.08 each. This open-market transaction involved Common Stock and was reported as an indirect acquisition, giving a total trade value of roughly $1,842 based on the disclosed per-share price.

Is the EHSI Form 4 purchase direct or indirect ownership?

The reported EHSI shares are held indirectly. The filing states ownership as indirect "By Haven Hospital LLC," meaning the shares are held through this entity rather than directly by Jeereddi Prasad Anjaneya, although he is the reporting person on the Form 4.

What is the total EHSI stake after the reported insider purchase?

Total indirectly held EHSI shares reached 227,423 after the trade. The Form 4 specifies this post-transaction balance for Common Stock, providing investors a view of the insider’s aggregate indirect position following the 1,707-share open-market purchase.

Did the EHSI Form 4 involve any options or derivative securities?

No derivative securities are reported in this Form 4. The transaction covers only non-derivative Common Stock, and the derivative section shows no remaining option or warrant positions associated with this filing, simplifying the ownership picture to straightforward share holdings.

Who executed the EHSI share purchase disclosed in this Form 4?

The purchase is attributed to Haven Hospital LLC. The filing lists the transaction as indirect ownership "By Haven Hospital LLC" with CEO and director Jeereddi Prasad Anjaneya as the reporting person, linking the entity’s holdings to his disclosed insider position.